Stocktoria
RXO, Inc. RXO
RXO, Inc. financials (annual)
Bars are annual figures from 2021 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.7B | $4.5B | $3.9B | $4.8B | $4.7B |
| SG&A expense | $832.0M | $666.0M | $591.0M | $640.0M | $539.0M |
| Operating income | -$79.0M | -$56.0M | $39.0M | $123.0M | $192.0M |
| Income tax | -$15.0M | -$14.0M | $0 | $27.0M | $41.0M |
| Net income | -$100.0M | -$290.0M | $4.0M | $92.0M | $150.0M |
| EPS (diluted) | $-0.59 | $-2.17 | $0.03 | $0.79 | $1.30 |
| Operating cash flow | $51.0M | -$12.0M | $89.0M | $310.0M | $155.0M |
| Free cash flow | -$8.0M | -$57.0M | $25.0M | $253.0M | $116.0M |
| Cash & equivalents | $17.0M | $35.0M | $5.0M | $98.0M | $29.0M |
| Total assets | $3.3B | $3.4B | $1.8B | $2.0B | $2.1B |
| Shareholders' equity | $1.5B | $1.6B | $594.0M | $587.0M | $1.1B |
Growth · year-over-year · Revenue CAGR 5.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue growth | +26.2% | +15.9% | -18.1% | +2.3% | — |
| Net income growth | — | -7350.0% | -95.7% | -38.7% | — |
| EPS growth | — | -7333.3% | -96.2% | -39.2% | — |
| Free cash flow growth | — | -328.0% | -90.1% | +118.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.